TP53 and hepatocellular carcinoma: One study combining a panel of 4 genes (TP53, CTNNB1, AXIN1, TERT), AFP and DCP discriminated 65 patients with HCC from 70 without HCC, with 85% sensitivity at 93% specificity in the training cohort.94